Picture of Sophia Genetics SA logo

SOPH — Sophia Genetics SA News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Sophia Genetics SA reports results for the quarter ended in June - Earnings Summary

* Sophia Genetics SA  SOPH.OQ  reported a quarterly adjusted
loss
of 31 cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 39 cents per share.
    * Revenue rose 14.6% to $11.67 million from a year ago;
analysts
expected $11.95 million. 
    * Sophia Genetics SA's reported EPS for the quarter was a
loss
of 39 cents​.
    * The mean earnings estimate of analysts had fallen by
about 5.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Sophia Genetics SA shares had risen by 40.9% this
quarter and
lost 63.8% so far this year.
    * The company reported a quarterly loss of $24.68 million.
    * Wall Street's median 12-month price target for Sophia
Genetics
SA is $14.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 01:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.39          -0.31          Beat
 Mar. 31 2022      -0.33          -0.34          Missed
 Dec. 31 2021      -0.36          -0.28          Beat
 Sep. 30 2021      -0.36          -0.30          Beat

Recent news on Sophia Genetics SA

See all news